press release
January 21, 2020
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
Ncardia Stem Cell Experts
INSPIRE: A European safety pharmacology training network
Ncardia Stem Cell Experts
